Forian Inc. (FORA) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $2.15. It has a SharesGrow Score of 57/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of FORA = $95.65 (+4348.8% from the current price, the stock appears undervalued). Analyst consensus target is FORA = $5 (+109.3% upside).
Valuation: FORA trades at a trailing Price-to-Earnings (P/E) of -23.3 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.16.
Financials: revenue is $30M, +7.2%/yr average growth. Net income is $3M (loss), growing at +10.9%/yr. Net profit margin is -9.5% (negative). Gross margin is 52.5% (-23 pp trend).
Balance sheet: total debt is $12,137 against $30M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 2.97 (strong liquidity). Debt-to-assets is 0%. Total assets: $44M.
Analyst outlook: 3 / 3 analysts rate FORA as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 91/100 (Pass), Growth 73/100 (Pass), Past 25/100 (Fail), Health 67/100 (Partial), Moat 35/100 (Fail), Future 100/100 (Pass), Income 10/100 (Fail).
